Role of Dopamine Receptors on Electroencephalographic Changes Produced by Repetitive Apomorphine Treatments in Rats.
10.4196/kjpp.2009.13.3.147
- Author:
Hwan Soo JANG
1
;
Ji Young KIM
;
Sang Heon KIM
;
Maan Gee LEE
Author Information
1. Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Korea. mglee@knu.ac.kr
- Publication Type:Original Article
- Keywords:
Apomorphine;
Dopamine D1 receptor;
Dopamine D2 receptor;
SCH-23390;
Haloperidol;
EEG;
Rat
- MeSH:
Animals;
Apomorphine;
Benzazepines;
Dopamine;
Electroencephalography;
Haloperidol;
Rats;
Receptors, Dopamine;
Receptors, Dopamine D1;
Receptors, Dopamine D2
- From:The Korean Journal of Physiology and Pharmacology
2009;13(3):147-151
- CountryRepublic of Korea
- Language:English
-
Abstract:
Repeated psychostimulants induce electroencephalographic (EEG) changes, which reflect adaptation of the neural substrate related to dopaminergic pathways. To study the role of dopamine receptors in EEG changes, we examined the effect of apomorphine, the dopamine D1 receptor antagonist, SCH-23390, and the D2 receptor antagonist, haloperidol, on EEG in rats. For single and repeated apomorphine treatment groups, the rats received saline or apomorphine for 4 days followed by a 3-day withdrawal period and then apomorphine (2.5 mg/kg, i.p.) challenge after pretreatment with saline, SCH-23390, or haloperidol on the day of the experiment. EEGs from the frontal and parietal cortices were recorded. On the frontal cortex, apomorphine decreased the power of all the frequency bands in the single treatment group, and increased the theta (4.5~8 Hz) and alpha (8~13 Hz) powers in the repeated treatment group. Changes in both groups were reversed to the control values by SCH-23390. On the parietal cortex, single apomorphine treatment decreased the power of some frequency bands, which were reversed by haloperidol but not by SCH-23390. Repeated apomorphine treatment did not produce significant changes in the power profile. These results show that adaptation of dopamine pathways by repeated apomorphine treatment could be identified with EEG changes such as increases in theta and alpha power of the frontal cortex, and this adaptation may occur through changes in the D1 receptor and/or the D2 receptor.
